Stock Earnings

Question 1

What are Coya Therapeutics Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Coya Therapeutics Inc has a total asset of $44, Net loss of $-14

Question 2

What are the key financial ratios for COYA?

Accepted Answer

Coya Therapeutics Inc's Current ratio is 11, has a Net margin is -466.66, sales per share of $0.19.

Question 3

How is Coya Therapeutics Inc's revenue broken down by segment or geography?

Accepted Answer

Coya Therapeutics Inc largest revenue segment is Proprietary Medicinal Products, at a revenue of 3,554,061 in the most earnings release.For geography, United States is the primary market for Coya Therapeutics Inc, at a revenue of 3,554,061.

Question 4

Is Coya Therapeutics Inc profitable?

Accepted Answer

no, according to the latest financial statements, Coya Therapeutics Inc has a net loss of $-14

Question 5

Does Coya Therapeutics Inc have any liabilities?

Accepted Answer

yes, Coya Therapeutics Inc has liability of 4

Question 6

How many outstanding shares for Coya Therapeutics Inc?

Accepted Answer

Coya Therapeutics Inc has a total outstanding shares of 16.7

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	3	6	0	0	0
Revenue Growth (YoY)	-100%	-50%	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	9	8	7	4	2	0
Research & Development	13	11	5	4	2	0
Operating Expenses	23	20	13	9	4	0
Other Non Operating Income (Expenses)	1	1	0	-2	0	0
Pretax Income	-21	-15	-7	-12	-4	0
Income Tax Expense	0	0	0	--	--	--
Net Income	-20	-14	-7	-12	-4	0
Net Income Growth	100%	100%	-42%	200%	--	--
Shares Outstanding (Diluted)	16.72	15.23	10.16	9.95	9.65	9.65
Shares Change (YoY)	12%	50%	2%	3%	0%	--
EPS (Diluted)	-1.21	-0.97	-0.78	-1.23	-0.51	-0.08
EPS Growth	81%	24%	-36%	141%	538%	--
Free Cash Flow	-16	-10	-11	-7	-4	0
Free Cash Flow Per Share	-0.95	-0.65	-1.08	-0.7	-0.41	0
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	-566.66%	-116.66%	0%	0%	0%
Profit Margin	0%	-466.66%	-116.66%	0%	0%	0%
Free Cash Flow Margin	0%	-333.33%	-183.33%	0%	0%	0%
EBITDA	-22	-17	-7	-9	-4	0
EBITDA Margin	0%	-566.66%	-116.66%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-22	-17	-7	-9	-4	0
EBIT Margin	0%	-566.66%	-116.66%	0%	0%	0%
Effective Tax Rate	0%	0%	0%	--	--	--

Coya Therapeutics Inc (COYA) Price

COYA Stock Price Chart

COYA Income

Follow-Up Questions